Skip to main content
OpenTrials

Clinical trial condition

Noonan Syndrome

Explore clinical trials studying Noonan Syndrome. Study availability and eligibility vary by location and protocol.

37 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Noonan Syndrome trial results

Completed

A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China

NCT03565003

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +40 more
Locations
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chinese PLA Central Hospital Beijing, Beijing Municipality, China
View Trial Details
Completed

A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC

NCT04959981

Conditions
Advanced Non-squamous Non-small-cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +20 more
Locations
  • City of Hope Duarte, California, United States
  • UC Irvine, Chao Family Comprehensive Cancer Center Orange, California, United States
  • UC Los Angeles Santa Monica, California, United States
  • University of Colorado Aurora, Colorado, United States
View Trial Details
Completed

Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC

NCT03989115

Conditions
Adnexal Diseases, Bronchial Diseases, Bronchial Neoplasms, +61 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • UC Irvine - Chao Family Comprehensive Cancer Center Orange, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
View all 24 locations
View Trial Details
Completed

Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome

NCT02713945

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +9 more
Locations
  • CHU Angers Unité d'endocrinologie pédiatrique Angers, France
  • CHU Bordeaux Unité de Génétique pédiatrique Bordeaux, France
  • Chu Dijon Dijon, France
  • CHRU Lille Unité d'endocrinologie pédiatrique Lille, France
View Trial Details
Completed

RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors

NCT04252339

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +10 more
Locations
  • Florida Cancer Specialist-Lake Mary Lake Mary, Florida, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)

NCT03435627

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +11 more
Locations
  • Novo Nordisk Investigational Site Asahikawa, Hokkaido, Japan
  • Novo Nordisk Investigational Site Fukuoka, Japan
  • Novo Nordisk Investigational Site Kanagawa, Japan
  • Novo Nordisk Investigational Site Kanagawa, Japan
View all 22 locations
View Trial Details
Completed

Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome

NCT01927861

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +11 more
Locations
  • Novo Nordisk Investigational Site Asahikawa, Hokkaido, Japan
  • Novo Nordisk Investigational Site Fukuoka, Japan
  • Novo Nordisk Investigational Site Fukuoka, Japan
  • Novo Nordisk Investigational Site Iruma-gun, Saitama, Japan
View all 27 locations
View Trial Details

Related conditions